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INTRODUCTION 
Nowadays, cancer is the second leading 
cause of death worldwide. In most countries, 
the incidence rate of cancers is increasing, 
which can be attributed to the aging of the 
population, and changes in lifestyle in cases 
such as smoking, physical activity, obesity, 
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ABSTRACT 
Background and aims: Bladder cancer is the most common tumor of the urinary tract 
and the ninth cancer in terms of incidence in both sexes in the world. Bladder cancer is 
the second most common cancer among men in Iran. The most important risk factors 
which attribute to the incidence of bladder cancer are tobacco usage, exposure to 
industrial materials, and chronic infection by Schistsoma. This study aimed to investigate 
the trend of death from bladder cancer in Iran. 
Methods: This study was conducted by the use of data on mortality in Iran during  
2006-10. Data on mortality from cancer within the study period were collected and 
entered on a pre-designed form. Mortality rates per 105 persons were calculated by age 
group and sex, and the trend of mortality from this cancer was determined. 
Results: The results from the calculation of mortality rates per 105 persons indicated that 
the death rate from bladder cancer is reduced from 1.12 to 1.09. The mortality rates 
during all the years under the study showed that increasing age increases the bladder 
cancer in men. 
Conclusion: No particular change was observed in the analysis of the trend of tobacco 
using in Iran in the last two decades, which can be considered as one of the causes of 
constancy of mortality trend from bladder cancer. However, given the increase in the 
number of people over 65 and the observed growing trend in bladder cancer incidence in 
various regions of the country, it is recommended that health policies are adopted in order 
to prevent the risk factors behind this type of cancer such as tobacco and harmful 
industrial materials. 
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and stress.1,2 Among cancers, bladder 
cancer is the most common tumour of the 
urinary tract, the ninth cancer in terms of 
incidence in both sexes in the world, the 
seventh leading cancer in men and the 
seventeenth in women.3,4 Bladder cancer is 
responsible for 7% and 2% of new cases of 
cancer in men and women respectively.5 
According to the latest statistics, 386, 300 
new cases and 150,200 deaths worldwide 
in 2008 were reported for bladder cancer.
6
 
Europe, North America and North Africa 
show the highest incidence.7 Incidence rate 
specific to bladder cancer in the Southeast 
Asia is found as 4.5 and 1.3 per 105 in 
men and women respectively.7 Bladder 
cancer is the second most common cancer 
in Iranian men with age-standardized 
incidence rate of 11.53 per 105, and 2.92 
per 105 in Iranian women.8 
The highest death rate from bladder 
cancer in the world is found in Egyptian 
men with 16.3 per 105 persons. This rate is 
twice the highest mortality rate in Europe 
(8.3 per 105 in Spain and 8 per 105 in the 
Netherlands) and more than four times the 
rate of death in United States of America 
with 3.7 per 105 persons per year.6 In 
Europe, the highest mortality rate in 
women has been observed between 2-3 per 
105 women in Denmark and England. In 
Iran, the rate of death from this cancer is 
1.7 in men and 0.5 in women and is 
calculated as 1 per 105 populations in both 
sex groups.8,9 
Smoking and exposure to industrial 
materials are regarded as the most important 
risk factors for bladder cancer in developed 
countries.7,9-11 Smoking is responsible for  
30-50% and exposure to industrial materials 
for 20% of all cases of bladder cancer which 
have been identified in the world.5,7 
However, chronic infection by Schistosoma 
is the most important risk factor in 
developing countries, especially in Egypt and 
Africa where this factor attributes to 50% of 
all cases of this cancer.4,6 The risk of bladder 
cancer incidence in smokers generally is  
2-4 times more likely than non-smokers.9 
Because the information of the disease 
mortality is essential for health planning, the 
aim of this study was to estimate the rate 
and trend of deaths from bladder cancer in 
Iranian population during 2006-10 years in 
order to present an overview of the rate of 
deaths due to this cancer in Iran. 
 
METHODS 
The present study was cross-sectional 
using data on mortality in Iran during  
2006-10. Data were collected by 
Technology and Applied Research and 
Information Management Centre of the 
Ministry of Health and Medical Education 
from various sources including National 
Organization for Civil Registration, 
cemeteries, hospitals, and care homes. The 
necessary data integration has been 
performed in the Ministry of Health and 
Medical Education.12 
In the present study, the data on the 
number of deaths from bladder cancer 
during 2006-10 in 29 provinces of Iran were 
obtained based on mortality in Iran after 
removing empty codes, and were entered in 
a pre-designed form. Number of deaths, 
mortality rate, male/female mortality ratio, 
and mortality rates in the age and sex groups 
were calculated and reported. Moreover, a 
picture of the trend of changes in mortality 
due to bladder cancer in Iran was drawn. 
 
RESULTS 
The present study has analysed the data 
on all deaths from bladder cancer in 2006 to 
2010 in all age and sex groups. During this 
period, 3075 cases of deaths from bladder 
cancer have been reported. 2354 cases of 
death were observed in men and 722 in 
women. Most cases of death in men have 
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occurred in 2006 with 504 cases reported 
and in women in 2006 with 166 cases. The 
statistics showed that the number of deaths 
in men is higher than women, and sex ratio 
of 3.26 was obtained in all the years under 
the study. Results from the calculation of 
mortality rates per 100,000 persons showed 
that mortality rate from bladder cancer was 
1.12 in 2006 and 1.09 in 2010. According to 
Table 1 and Figure 1, mortality rates during 
all the years under the study showed a 
relatively steady trend of bladder cancer in 
men and women. The rate in men was 
1.74/105 in 1385 and 1.57/105 in 2010. The 
rate in women has reached from 0.49 in 
2006 to 0.60 in 2010. 
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Figure 1: The rate of death from Bladder 
cancer per hundred thousand people in the 
study group sex 
 
Table 1: Mortality from Bladder cancer per hundred thousand people in the study group sex 
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Figure 2: The rate of death from bladder 
cancer per hundred thousand people in the 
age groups studied 
 
 
Calculation of mortality rate due to 
bladder cancer in Table 2 and Figure 2 in 
all the years under the study in age and sex 
groups showed that the rate of death from 
this cancer increases with age. The lowest 
death rate due to the cancer has been 
reported in the age group below 5 years 
and 14-5 years, while mortality rate from 
the cancer has increased with age and in 
the age group above 70 years, and has 
grown from 21.2/105 in 2006 to 23.68/105 
in 2010. 
 Sex ratio Crude mortality rate Mortality per hundred thousand Year of study 
Total Men Woman Total Men Woman 
3.65 642 504 138 1.12 1.74 0.49 2006 
3.41 582 451 132 1.09 1.67 0.50 2007 
3.11 621 470 151 1.15 1.72 0.56 2008 
3.62 625 490 135 1.14 1.78 0.50 2009 
2.64 605 439 166 1.09 1.57 0.60 2010 
3.26 3075 2354 722    Total 
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Table 2: The rate of death from Bladder cancer per hundred thousand in the year under study, by 
sex and age group 
Above 70 years 50-69 15-49 5-14 Under 5 years Year of study 
T M W T M W T M W T M W T M W 
21.02 30.96 9.60 2.84 4.47 1.24 0.14 0.23 0.06 0 0 0 0 0 0 2006 
21.29 29.90 11.51 2.83 4.79 0.92 0.11 0.17 0.04 0 0 0 0 0 0 2007 
21.67 30.85 11.41 3.24 5.18 1.35 0.12 0.16 0.07 0 0 0 0 0 0 2008 
22.43 33.26 10.52 3.01 4.79 1.29 0.11 0.19 0.02 0 0 0 0 0 0 2009 
23.68 32.95 13.65 2.36 3.82 1.27 0.08 0.13 0.04 0 0 0 0 0 0 2010 
 
DISCUSSION 
The results indicate a steady trend from 
1.12/105 in 1385 to 1.09/105 in 2010 for the 
mortality rate from bladder cancer in Iran over 
the five-year period. The trend corresponds 
with the bladder cancer mortality trend in 
Spain;
13
 whereas, bladder cancer mortality and 
incidence has followed a downward trend in 
Europe and America due to the decline in the 
prevalence of tobacco use.
6
 The rate of 
tobacco consumption in America has 
decreased from 52% in 1965 to 28% in men 
and from 34% to 23% in women. In Europe, 
the same rate has declined by approximately 
16% in men and 12% in women over the last 
decade.
4
 In Algeria, the prevalence of 
smoking in men during 1978-2005 has 
increased from 7.7% to 28.6%, and at the 
same time bladder cancer in men has 
experienced a growth rate of 5.9%. The rate 
has increased by 3.5% in the age group of  
45-64 years but it has been equivalent to 8% 
in the age groups above 65 years.
14
 In Western 
countries, tobacco consumption has been 
identified as the cause of 50% of bladder 
cancer cases in men and 35% of bladder 
cancer cases in women. Changes in the 
prevalence of tobacco use have been the most 
important cause of the decline of this cancer 
incidence and mortality in Europe and 
America.
4,7,9
 Unfortunately, based on the 
geographical map, tobacco consumption has 
shifted away from developed countries to 
developing countries. The World Health 
Organization has reported increased tobacco 
consumption among men and women in most 
developing countries in the world such as 
Africa, the Middle East, Eastern Europe and 
some Asian countries and Australia. The result 
is an increase in bladder cancer incidence and 
mortality in these countries. It should be noted 
that the main burden of bladder cancer falls on 
the developed countries at the present time. 
However, due to the developing countries' 
increased exposure to this cancer, the burden 
is expected to be transferred to these countries.
4
 
However, no particular change has been 
observed in the study of the trend of tobacco 
use in Iran in the past 2 decades. Based on the 
studies, the prevalence of tobacco consumption 
in Iran has been totally 14.6% in 1991 (27.2% 
in men and 3.4% in women) and 14.8% in 
2007 that 26.1% of the total rate has been 
reported in men and 3.2% in women.
15
 While 
in the studies carried out in Chile, mortality rate 
from bladder cancer caused by exposure to 
arsenic in water has been.
10
 
In Egypt, mortality and morbidity from 
bladder cancer has significantly decreased due 
to the control of chronic infection by 
Schistosoma, but unfortunately part of this 
decrease was offset by an increase in tobacco 
use.
6 
Bladder cancer incidence and mortality 
has followed a growing trend in Algerian men 
but a steady trend in women.
14
 Bladder cancer 
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is routinely observed at older ages so that 
more than 90% of the cases are identified in 
persons above 55 years old.
4
 According to the 
results obtained from the study, the calculation 
of bladder cancer mortality rates in different 
age groups shows that the rate of death caused 
from this cancer increases with age and most 
cases of death have been reported in the age 
group above 70 years old. A large number of 
studies have suggested that the bladder cancer 
risk is the highest among people aged about 60-
70.
16
 Based on the studies conducted in 
Algeria, it is observed that the bladder cancer 
incidence has over 8% growth rate in the age 
group above 65years old.
14
 It seems that given 
the high incidence of bladder cancer in persons 
over the age of 60, death rate from the cancer is 
higher among cases over 70 years of age. 
Bladder cancer is the second most 
common cancer in men in Isfahan and the 
third leading cancer in Markazi province.
17,18
 
In the East Azerbaijan province, bladder 
cancer in men is the second and in the general 
population is the third leading cancer, the age-
standardized incidence rate is 16.76/105 in 
men, 5/105 in women and 11.2/105 in general 
population.
3
 In Yazd and Kurdistan, bladder 
cancer is the fourth leading cancer in both 
sexes with prevalence rate of 7.5%, and it is 
the second common cancer in men in Yazd 
with prevalence rate of 11.7%.
19,20
 The highest 
cancer incidence rate per 100000 persons in 
the elderly over the age of 60 years old in Iran 
over a 5-year trend has been related to bladder 
cancer in Kermanshah province.
21
 
All over the world, bladder cancer in men 
is 3-4 times more than women (5,7), which 
corresponds to the study carried out by 
Akbarzade in Mazandaran and male/female 
ratio in Beigi's study was 5.5.
11,22
 The results 
of this study show that the number of deaths 
from bladder cancer in men is larger than in 
women and men are at a greater risk of death 
from bladder cancer. The sex ratio estimated 
in the study is 3.26 which is corresponded to 
the study conducted by Mousavi. In Mousavi's 
study, the mortality rate from bladder cancer 
in Iran was 1.7/105 in men and 0.5/105 in 
women.
8
 Bladder cancer mortality rate in 
Spain in men is 5 times more than women and 
this rate corresponds to the results of the 
study.
13
 The higher rate of death from bladder 
cancer in men corresponds to age standardized 
mortality rate in the developed and developing 
regions.
6 
However, due to the increase in the 
number of people over 65 years old and the 
observed growing trend in bladder cancer 
incidence in various regions of the country, it 
is recommended that health policies are 
adopted in order to prevent risk factors behind 
this type of cancer such as tobacco and 
harmful industrial materials.
3,5,8
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